Korro Bio, Inc.
KRRO
$10.18
-$0.90-8.12%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -29.84% | -40.30% | -0.69% | -7.10% | -7.75% |
| Total Depreciation and Amortization | -15.48% | 20.06% | 48.13% | 36.38% | 14.58% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 586.47% | 511.64% | -8.25% | -23.10% | -20.04% |
| Change in Net Operating Assets | -102.43% | -132.57% | 154.59% | 189.56% | 1,851.38% |
| Cash from Operations | -12.05% | -30.77% | 7.24% | 3.02% | 9.86% |
| Capital Expenditure | 96.62% | 97.11% | 89.58% | 51.09% | -3.99% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 71.59% | 142.21% | 127.08% | 113.34% | -3,727.25% |
| Cash from Investing | 75.25% | 135.67% | 121.53% | 105.64% | -755.19% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 27.87% | -99.01% | -99.44% | -99.17% | -55.13% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 27.87% | -99.01% | -99.42% | -99.13% | -51.31% |
| Foreign Exchange rate Adjustments | 1,075.00% | 1,700.00% | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 96.87% | 70.35% | -338.88% | -286.37% | -223.98% |